Thomas E Prod'Homme

Title: Thomas E Prod'Homme: Innovator in Neurodegeneration Treatment

Introduction

Thomas E Prod'Homme is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of neurodegeneration treatment, holding a total of 3 patents. His work focuses on innovative methods that aim to address neurodegenerative diseases, including Alzheimer's Disease.

Latest Patents

Prod'Homme's latest patents revolve around the discovery of Fc-containing polypeptides that include branched glycans. These polypeptides are sialylated on the branched glycan, specifically on an α 1,3 and/or α 1,6 arm in the Fc region's N-linked glycosylation site. The invention highlights the utility of these polypeptides in treating neurodegeneration. The present disclosure provides methods for treating neurodegenerative diseases by administering compositions containing such Fc-containing polypeptides. Additionally, it outlines methods for evaluating, identifying, and producing these polypeptides for therapeutic purposes.

Career Highlights

Thomas E Prod'Homme is currently associated with Momenta Pharmaceuticals, Inc., where he continues to advance his research in neurodegeneration. His innovative approaches have positioned him as a key figure in the development of new treatments for debilitating diseases.

Collaborations

Prod'Homme collaborates with esteemed colleagues, including Leona E Ling and Carlos J Bosques. Their combined expertise fosters a productive environment for groundbreaking research and development.

Conclusion

Thomas E Prod'Homme's contributions to the field of neurodegeneration treatment exemplify the impact of innovative research on healthcare. His work continues to pave the way for new therapeutic strategies that could significantly improve the lives of those affected by neurodegenerative diseases.